Anthropic Sought Data from Big Pharma, Faced Near-Unanimous Rejection
joecole · x · 2026-07-07
David Friedberg revealed that Anthropic proactively contacted major pharmaceutical companies to request proprietary data for AI R&D, but almost all declined the collaboration. This highlights the data barriers AI companies face when entering the highly regulated life sciences sector and suggests that Big Pharma maintains a strong protective stance regarding AI data partnerships. (The original post was truncated; full context is unknown.)
Related event: Anthropic Denied Data Access by Big Pharma(2 posts)→
More from Companies & People
- RSS launches under OMSF to push structural biology data modeling at scale — MoAlQuraishi · 2026-07-22
- Moonshot AI reportedly targets a $50B round ahead of Hong Kong listing — ctjlewis · 2026-07-22
- Annotated transcript of a Claude Code team interview is now available — trq212 · 2026-07-22
- AI industry astroturfing roundup tracks the sector’s fake-grassroots problem — ShakeelHashim · 2026-07-22
- Enterprise AI’s real value is in agentic workflows, not generic chatbots — irfan__77 · 2026-07-22
- Tesla expands Robotaxi rides to seven areas, including new Orlando and Tampa zones — elonmusk · 2026-07-22